Artwork

Content provided by Mission Based Media, Ltd and Digital Health Today with Eugene Borukhovich. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Mission Based Media, Ltd and Digital Health Today with Eugene Borukhovich or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Player FM - Podcast App
Go offline with the Player FM app!

Ep60: Treating Adolescent Depression with DTx

30:25
 
Share
 

Manage episode 360966554 series 2857558
Content provided by Mission Based Media, Ltd and Digital Health Today with Eugene Borukhovich. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Mission Based Media, Ltd and Digital Health Today with Eugene Borukhovich or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

In this episode, we hear from Benjamin Alouf, MD, Chief Medical Officer at Limbix. In their own words, Limbix is the first digital therapeutic for adolescent depression.

In this episode, we cover:

  • Origin of the company and story behind the name 'Limbix'
  • The funding journey and key milestones achieved
  • The choice to focus on the young adult population in particular
  • Patient experience with SparkRx
  • Defining good patient engagement in adolescent mental health
  • Evidence generation and FDA submission process
  • Business hypthothesis and scaling plan
  • The future of the PDT market

Guest Links and Resources:

Host Links:

Digital Therapeutics Podcast would not be possible without the support of leading DTx organizations. Thank you to:

> Presenting Partner: Amalgam Rx

> Contributing Partners and Sponsors: Akili | Bayer G4A | Lindus Health

Follow Digital Health Today:

Browse Episodes | Twitter | LinkedIn | Facebook | Instagram

Follow Health Podcast Network:

Browse Shows | LinkedIn | Twitter | Facebook | Instagram

  continue reading

102 episodes

Artwork
iconShare
 
Manage episode 360966554 series 2857558
Content provided by Mission Based Media, Ltd and Digital Health Today with Eugene Borukhovich. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Mission Based Media, Ltd and Digital Health Today with Eugene Borukhovich or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

In this episode, we hear from Benjamin Alouf, MD, Chief Medical Officer at Limbix. In their own words, Limbix is the first digital therapeutic for adolescent depression.

In this episode, we cover:

  • Origin of the company and story behind the name 'Limbix'
  • The funding journey and key milestones achieved
  • The choice to focus on the young adult population in particular
  • Patient experience with SparkRx
  • Defining good patient engagement in adolescent mental health
  • Evidence generation and FDA submission process
  • Business hypthothesis and scaling plan
  • The future of the PDT market

Guest Links and Resources:

Host Links:

Digital Therapeutics Podcast would not be possible without the support of leading DTx organizations. Thank you to:

> Presenting Partner: Amalgam Rx

> Contributing Partners and Sponsors: Akili | Bayer G4A | Lindus Health

Follow Digital Health Today:

Browse Episodes | Twitter | LinkedIn | Facebook | Instagram

Follow Health Podcast Network:

Browse Shows | LinkedIn | Twitter | Facebook | Instagram

  continue reading

102 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Quick Reference Guide